$0.25
Qualigen Therapeutics is a biotechnology business based in the US. Qualigen Therapeutics shares (QLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Qualigen Therapeutics employs 4 staff and has a trailing 12-month revenue of around $5 million.
Our top picks for where to buy Qualigen Therapeutics stock
How to buy Qualigen Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – QLGN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Qualigen Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Qualigen Therapeutics stock price (NASDAQ: QLGN)
Use our graph to track the performance of QLGN stocks over time.Qualigen Therapeutics shares at a glance
Latest market close | $0.27 |
---|---|
52-week range | $0.14 - $1.26 |
50-day moving average | $0.25 |
200-day moving average | $0.46 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.16 |
Is it a good time to buy Qualigen Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Qualigen Therapeutics price performance over time
Historical closes compared with the close of $0.2702 from 2024-07-22
1 week (2024-07-17) | -12.87% |
---|---|
1 month (2024-06-24) | 40.00% |
3 months (2024-04-24) | -12.53% |
6 months (2024-01-24) | -44.91% |
1 year (2023-07-24) | -74.02% |
---|---|
2 years (2022-07-20) | -39.96% |
3 years (2021-07-23) | 1.76 |
5 years (2019-07-24) | 24.5 |
Qualigen Therapeutics financials
Revenue TTM | $5 million |
---|---|
Gross profit TTM | $680,801 |
Return on assets TTM | -74.45% |
Return on equity TTM | -841.66% |
Profit margin | 0% |
Book value | $-0.54 |
Market Capitalization | $3.3 million |
TTM: trailing 12 months
Qualigen Therapeutics share dividends
We're not expecting Qualigen Therapeutics to pay a dividend over the next 12 months.
Have Qualigen Therapeutics's shares ever split?
Qualigen Therapeutics's shares were split on a 1:10 basis on 22 November 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Qualigen Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Qualigen Therapeutics shares which in turn could have impacted Qualigen Therapeutics's share price.
Qualigen Therapeutics share price volatility
Over the last 12 months, Qualigen Therapeutics's shares have ranged in value from as little as $0.1449 up to $1.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Qualigen Therapeutics's is 0.082. This would suggest that Qualigen Therapeutics's shares are less volatile than average (for this exchange).
Qualigen Therapeutics overview
Qualigen Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. .
Frequently asked questions
What percentage of Qualigen Therapeutics is owned by insiders or institutions?Currently 5.976% of Qualigen Therapeutics shares are held by insiders and 2.306% by institutions. How many people work for Qualigen Therapeutics?
Latest data suggests 4 work at Qualigen Therapeutics. When does the fiscal year end for Qualigen Therapeutics?
Qualigen Therapeutics's fiscal year ends in December. Where is Qualigen Therapeutics based?
Qualigen Therapeutics's address is: 2042 Corte Del Nogal, Carlsbad, CA, United States, 92011 What is Qualigen Therapeutics's ISIN number?
Qualigen Therapeutics's international securities identification number is: US74754R1032
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question